Published Date :2018-07-30 Pages :180 Category : Medical Devices
The ENT Devices Market was worth USD 9.68 billion in 2014 and is expected to reach approximately USD 17.24 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.62% during the forecast period. Increasing populations of elderly people, expanding predominance of ENT related issues, developing government activities are among the key patterns fortifying business sector development.
Published Date :2018-07-30 Pages :190 Category : Biotechnology
The Bone Grafts and Substitutes Market was worth USD 2.38 billion in 2014 and is expected to reach approximately USD 3.40 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 4.05% during the forecast period. Bone grafts and substitutes are used to repair fractures in the bone, bone development, and osseous reconstruction as these materials are having osteoconductive and osteoinductive properties.
Published Date :2018-07-30 Pages :190 Category : Healthcare IT
The Clinical Trial Management System Market was worth USD 0.45 billion in 2014 and is expected to reach approximately USD 1.31 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 12.56% during the forecast period. Clinical trial management alludes to the integration, collection and integration of clinical trial data.
Published Date :2018-07-30 Pages :180 Category : Medical Devices
The Extremities Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period. Body extremities are extended body particularly associated with locomotive capacities.
Published Date :2018-07-30 Pages :190 Category : Medical Devices
The Hearing Screening and Diagnostic Devices Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period. Hearing Disability is considered if the hearing loss is in excess of 40 dB in adults and 30dB in youngsters from age gather 0-14 years.
Published Date :2018-07-30 Pages :190 Category : Biotechnology
The High-performance Liquid Chromatography Market was worth USD 2.88 billion in 2014 and is expected to reach approximately USD 4.55 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 5.21% during the forecast period. High-performance liquid chromatography is a diagnostic procedure used to separate, identify, and measure every part in a mixture
Published Date :2018-07-30 Pages :180 Category : Medical Devices
The Orthopedic Orthotic Devices Market is expected to gain positive market share by 2023, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Orthotic can be characterized as the brace, support, or splint used to prevent, align, support, or to rectify the working of moving body parts, for example, knee, neck, wrist, shoulder and so on.
Published Date :2018-07-30 Pages :190 Category : Medical Devices
Orthopedic Soft Tissue Repair Market was worth USD 6.56 billion in 2014 and is expected to reach approximately USD 12.91 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 7.81% during the forecast period. The essential driver of the market is sport injuries, which is assessed to add to the development of the market significantly. Injuries that are caused due to sports are the most well-known reasons resulting in muscle damage.
Published Date :2018-07-30 Pages :180 Category : Healthcare IT
The Preventive Healthcare Technologies and Services Market was worth USD 80.72 billion in 2014 and is expected to reach approximately USD 185.26 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.67% during the forecast period. Preventive healthcare services incorporates measures made for taking preventative steps of illnesses caused either by analysis of the sickness or immunization.
Published Date :2018-07-30 Pages :190 Category : Medical Devices
Respiratory Care Devices Market was worth USD 14.09 billion in 2014 and is expected to reach approximately USD 31.94 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.52% during the forecast period. Respiratory care devices fall under the classification of therapeutic devices that are utilized for management, treatment, evaluation, control, diagnostic and care of patients with an irregularity in the cardiopulmonary system.
Published Date :2024-04-10
Published Date :2024-03-13
Published Date :2024-01-09
Published Date :2023-02-06
Published Date :2023-02-01